`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.
`Petitioners,
`
`v.
`
`TELEFLEX INNOVATIONS S.A.R.L.
`Patent Owner.
`
`
`
`
`Case IPR2020-01343
`U.S. Patent No. RE 46,116
`
`
`
`
`
`
`
`PATENT OWNER UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`

`

`TABLE OF EXHIBITS
`
`Exhibit Description
`2001 Defendants’ Responses to Plaintiffs’ First Set of Document Requests,
`Vascular Sols. LLC v. Medtronic, Inc., 19-cv-01760-PJS-TNL (D. Minn.
`Aug. 15, 2019)
`2002 Defendants’ Opposition to Plaintiffs’ Motion for Preliminary Injunction
`(Redacted), Vascular Sols. LLC v. Medtronic, Inc., 19-cv-01760-PJS-
`TNL, Dkt. 104 (D. Minn., Nov. 15, 2019)
`2003 Email dated January 24, 2020, from Derek Vandenburgh to Kurt
`Niederluecke
`2004 Email dated July 3, 2019, from Derek Vandenburgh to Paik Saber and
`Matthew Anderson
`2005 Email dated July 16, 2019, from Lora Friedemann to Joe Winkels and
`Kurt Niederluecke
`2006 Declaration of Alexander Rinn, Vascular Sols. LLC v. Medtronic, Inc.,
`19-cv-01760-PJS-TNL, Dkt. 93 (D. Minn., Oct. 16, 2019)
`Invoice from MicroGroup
`2007
`Invoices from Medical Profiles & Engineering
`2008
`Invoice from MicroGroup
`2009
`Invoice from Mountain Machine, Inc.
`2010
`Invoice from Medical Engineering & Design Inc.
`2011
`[Reserved]
`2012
`2013 Sales Order from SPECTRAlytics
`2014 Photos of Component of GuideLiner Prototype
`2015
`[Reserved]
`2016
`Invoice from Medtronic
`2017 Memo Regarding Market Feasibility for the GuideLiner catheters
` – PROTECTIVE ORDER MATERIAL
`2018 PowerPoint presentation titled “New Products on the Horizon”
` – PROTECTIVE ORDER MATERIAL
`2019 Redacted, Excerpted Fax to Patterson Law Firm
`2020 Sales Order and Invoice from SPECTRAlytics
`2021
`Invoice from Medical Engineering & Design
`2022 Computerized Design Drawing of a GuideLiner
`2023 Redacted Client/Matter Form from Patterson Law Firm
`2024 Product Requirements: GuideLiner Catheter System
`2025 Clinical Technical Report
`
`

`

`Invoice from MicroGroup
`2026
`Invoice from Johnson Matthey Inc (Shape Memory Applications, Inc.)
`2027
`Invoice from SPECTRAlytics
`2028
`Invoices from Medical Profiles & Engineering
`2029
`Invoice from Automation & Metrology Inc.
`2030
`Invoice from Automation & Metrology Inc.
`2031
`Invoice from Farlow’s Scientific Glassblowing, Inc.
`2032
`Invoice from Farlow’s Scientific Glassblowing, Inc.
`2033
`Invoice from Farlow’s Scientific Glassblowing, Inc.
`2034
`Invoice from Farlow’s Scientific Glassblowing, Inc.
`2035
`2036 Research and Development Update July 2005 – PROTECTIVE ORDER
`MATERIAL
`2037 Exhibit BB to Declaration of Lora M. Friedemann in Opposition to
`Plaintiffs’ Motion for Preliminary Injunction – PROTECTIVE ORDER
`MATERIAL
`2038 Exhibit 36 to the Declaration of Kurt J. Niederlueke in Opposition to
`Plaintiffs’ Motion for Preliminary Injunction – PROTECTIVE ORDER
`MATERIAL
`2039 Declaration of Deborah Schmalz
`2040 Weekly Staff Meeting Memorandum
`2041 Business Update Section of Materials Presented to the Vascular
`Solutions Board of Directors October 2005 – PROTECTIVE ORDER
`MATERIAL
`[Reserved]
`2042
`[Reserved]
`2043
`[Reserved]
`2044
`[Reserved]
`2045
`2046 Declaration of Howard Root in Support of Plaintiff’s Motion for
`Preliminary Injunction, Vascular Solutions, Inc. v. Boston Scientific
`Corporation, 13-cv-01172 (JRT-SER) (D. Minn), Dkt. 12
`[Reserved]
`2047
`[Reserved]
`2048
`[Reserved]
`2049
`[Reserved]
`2050
`[Reserved]
`2051
`2052 Drawings Submitted with Ressemann U.S. Patent App. 10/214,712
`2053
`[Reserved]
`2054
`[Reserved]
`
`

`

`2055 Article Titled: Understanding Low-Friction Coatings for Medical
`Devices
`2056 Expert Report of Peter T. Keith on Infringement, Claim Coverage, and
`Lack of Acceptable Noninfringing Alternatives, QXMédical, LLC v.
`Vascular Solutions LLC, 17-cv-01969 (D. Minn.), Dkt. 125-22
`2057 Teleflex Product Patents Website
`2058 Confidential Presentation – PROTECTIVE ORDER MATERIAL
`2059
`[Reserved]
`2060 Globe Newswire: Teleflex Announces Tenth Anniversary of GuideLiner
`Catheter Product Line
`2061 GuideLiner Marketing Material V1 Catheter
`2062 GuideLiner Marketing Material V2 Catheter
`2063 GuideLiner Marketing Material: That’s A Real Game Changer
`2064
`[Reserved]
`2065 GuideLiner Catheter Bibliography
`2066 Physician Testimonial Authorizations
`2067 Rao, U., et al., The GuideLiner “child” catheter, EuroIntervention 2010
`6:277-279
`2068 Defendants’ Answer, Defenses, and Counterclaims to Plaintiffs’
`Complaint, Vascular Solutions LLC v. Medtronic, Inc., 19-cv-01760-
`PJS-TNL (D. Minn.), Dkt. 16
`2069 Exhibit E to Complaint, Vascular Solutions LLC v. Medtronic, Inc., 19-
`cv-01760-PJS-TNL (D. Minn.), Dkt. 1-5
`2070 Medtronic comparison of guide extension catheters
`2071 Exhibit A to Complaint, Vascular Solutions LLC v. Medtronic, Inc., 19-
`cv-01760-PJS-TNL (D. Minn.), Dkt. 1-1
`2072 Declaration of Peter Keith in Support of Plaintiffs’ Motion for
`Preliminary Injunction, Vascular Solutions LLC v. Medtronic, Inc., 19-
`cv-01760-PJS-TNL (D. Minn.), Dkt. 77
`2073 Declaration of Alexander S. Rinn
`2074
`[Reserved]
`2075
`[Reserved]
`2076
`[Reserved]
`2077
`[Reserved]
`2078
`[Reserved]
`2079
`[Reserved]
`2080
`[Reserved]
`2081
`[Reserved]
`2082
`[Reserved]
`
`

`

`[Reserved]
`2083
`[Reserved]
`2084
`2085 Exhibit introduced at depositions of Stephen J.D. Brecker and Richard
`A. Hillstead – Ressemann Figure 16D, Annotated
`2086 Exhibit introduced at depositions of Stephen J.D. Brecker and Richard
`A. Hillstead – Ressemann Cross-Section A-A Drawing, Annotated
`2087 Declaration of Joseph W. Winkels in Support of Patent Owner’s
`Unopposed Motion for Pro Hac Vice Admission
`2088 Declaration of Peter M. Kohlhepp in Support of Patent Owner’s
`Unopposed Motion for Pro Hac Vice Admission
`Invoice and Purchase Orders from Medical Engineering & Design, Inc.
`2089
`Invoices from Farlow’s Scientific Glassblowing, Inc.
`2090
`Invoices and Certificate of Compliance from MicroGroup, Inc.
`2091
`Invoice and Purchase Orders from Medical Engineering & Design, Inc.
`2092
`Invoices and Packing Slip from Automation & Metrology, Inc.
`2093
`Invoices and Certificate of Compliance from MicroGroup, Inc.
`2094
`2095 SPECTRAlytics Certificates of Completion
`2096
`Invoice from Patterson, Thuente, Skaar & Christensen, P.A. (Redacted)
`2097
`Invoices from Farlow’s Scientific Glassblowing, Inc.
`2098 Patterson, Thuente, Skaar & Christensen, P.A.’s Privilege Log
`2099 VSI Planned Production Development Projects
`2100 Vascular Solutions, Inc. 2006 Strategic Objectives (Redacted)
`2101
`Invoice from Patterson, Thuente, Skaar & Christensen, P.A. (Redacted)
`2102 Redacted, Excerpted Fax to Patterson Law Firm
`2103
`Invoice from Patterson, Thuente, Skaar & Christensen, P.A. (Redacted)
`2104
`Invoices from Vita Needle Company
`2105 Vascular Solutions, Inc. Budget to Actual Variances (Redacted)
`2106
`Invoices and Packing Lists from LSA
`2107
`Invoices and Certificate of Completion from The MicroGroup, Inc.
`2108
`Invoices and Packing Lists from LSA
`2109 GuideLiner Team Meeting Agenda
`2110
`Invoices and Certificate of Completion from The MicroGroup, Inc.
`2111 SPECTRAlytics Certificates of Completion
`2112
`Invoices from Farlow’s Scientific Glassblowing, Inc.
`2113 Engineering Drawings
`2114 Engineering Drawing
`2115 Engineering Drawings
`2116 Deposition Transcripts of Stephen J.D. Brecker, M.D. dated August 11,
`2020 and September 14, 2020
`
`

`

`Invoices from Patterson, Thuente, Skaar & Christensen, P.A. (Redacted)
`2117
`2118 Declaration of Howard Root Submitted in Connection with Patent
`Owner’s Responses
`2119 Declaration of Gregg Sutton
`2120 Declaration of Mark Goemer
`2121 Declaration of Amanda O’Neil
`2122 Declaration of Steve Erb
`2123 Declaration of Peter Keith Regarding Conception and Reduction to
`Practice Submitted in Connection with Patent Owner’s Responses
`[Reserved]
`2124
`[Reserved]
`2125
`[Reserved]
`2126
`2127 Memo Regarding Market Feasibility for the GuideLiner catheters
`(Redacted)
`2128 Memo Regarding Market Feasibility for the GuideLiner catheters
`(Redacted)
`2129 PowerPoint presentation titled “New Products on the Horizon”
`(Redacted)
`2130 Research and Development Update July 2005 (Redacted)
`2131 Vascular Solutions, Inc. 2006 Strategic Objectives (Redacted)
`2132 Research & Development Update – July 2008 (Redacted)
`2133 Business Update Section of Materials Presented to the Vascular
`Solutions Board of Directors October 2005 (Redacted)
`2134 Vascular Solutions, Inc. Research & Development Update – January
`2006 (Redacted)
`2135 Mozid, et al., “The Utility of a Guideliner™ Catheter in Retrograde
`Percutaneous Coronary Intervention of a Chronic Total Occlusion With
`Reverse CARD – The “Capture” Technique,” Catheterization and
`Cardiovascular Interventions, pp. 929-932 (2004)
`2136 Candilio, et al., “Subadventitial Advancement of a Mother-and-Child
`Catheter to Allow Successful Recanalization of a Complex In-Stent
`Chronic Total Occlusion: Testing the Resistance of the Adventitia,” J.
`Invasive. Cardiol, E190-E194 (2017)
`2137 Deposition Transcripts of Richard A. Hillstead, Ph.D. dated September
`11, 2020 and September 15, 2020
`2138 Declaration of Peter T. Keith
`2139 Engineering Drawings – PROTECTIVE ORDER MATERIAL
`2140 Engineering Drawings – PROTECTIVE ORDER MATERIAL
`2141 Engineering Drawings – PROTECTIVE ORDER MATERIAL
`
`

`

`2142 GuideLiner® Catheter Instructions for Use
`2143 GuideLiner® V2 Catheter Instructions for Use
`2144 GuideLiner® V3 Catheter Instructions for Use
`2145 Declaration of Dr. John J. Graham, MB ChB, MRCP (UK)
`2146 Boyle, et al., “Catheter-induced coronary artery dissection: Risk factors,
`prevention and management,” J. Invasive. Cardiol., pp. 500-503 (2006)
`2147 Dunning, et al., “Iatrogenic Coronary Artery Dissections Extending Into
`and Involving the Aortic Root,” Cathet. Cardiovasc. Intervent., pp. 387-
`393 (2000)
`2148 Hatem, et al., “Zero contrast retrograde chronic total occlusions
`percutaneous coronary intervention: a case series,” Eur. Heart J. – Case
`Reports (2017)
`2149 Meerkin, David, “Optimization of Guide Catheter Support: What are my
`Options?” (2010)
`2150 Ryan, et al., “Guidelines for Percutaneous Transluminal Coronary
`Angioplasty,” AHIA/ACC Task Force Circulation, Vol 88, No 6,
`(December 1993) 2987-3007
`2151 Declaration of Dr. Lorenzo Azzalini
`2152
`[Reserved]
`2153 Declaration of Steve Jagodzinkski – PROTECTIVE ORDER
`MATERIAL
`2154 GuideLiner 2009 Sales Spreadsheet – PROTECTIVE ORDER
`MATERIAL
`2155 GuideLiner Brochure 2009
`2156 GuideLiner Brochure 2010
`2157 GuideLiner Brochure 2011
`2158 GuideLiner Brochure 2012
`2159 GuideLiner Brochure 2013
`2160 GuideLiner Brochure 2014
`2161 GuideLiner Brochure 2015
`2162 GuideLiner Brochure 2016
`2163 GuideLiner Brochure 2017
`2164 GuideLiner Brochure 2018
`2165 GuideLiner Brochure 2019
`2166 Eddin, et al., “Transradial interventions with the GuideLiner catheter:
`Role of proximal vessel angulation,” Cardiovascular Revascularization
`Medicine, 14 (2013) 275–279
`
`

`

`2169
`
`2167 Moscucci, Mauro, editor. Grossman & Baim’s Cardiac Cathererization,
`Angiography, and Intervention. 8th Ed., Lippincott Williams & Wilkins,
`2014
`2168 Kovacic, et al., “GuideLiner Mother-and-Child Guide Catheter
`Extension: A Simple Adjunctive Tool in PCI for Balloon Uncrossable
`Chronic Total Occlusions,” J. of Interventional Cardiol., Vol 26, No. 4,
`2013, 343-350
`de Man, et al., “Usefulness and safety of the Guideliner catheter to
`enhance intubation and support of guide catheters: insights from the
`Twente Guideliner registry,” EuroIntervention 8 (2012) 336-344
`2170 Unzué, et al., “The GuideLiner® Catheter in Complex Coronary
`Interventions,” Scientific letters / Rev Esp Cardiol. 2012;65(5):479–488
`2171 Park, et al., “Guideliner Microcatheter to Improve Back-Up Support
`During a Complex Coronary Stenting Procedure Through a Tortuous
`Left Internal Mammary Graft,” J. Invasive Cardiol. 2012;24(4):E77-E79
`[Reserved]
`2172
`2173 Serajian, et al., “Novel Use of a GuideLiner Catheter to Visualize Distal
`LAD After LIMA Anastomosis in Selective Coronary Angiography,” J.
`Invasive Cardiol. 2012;24(2):E30-E31
`2174 Thomas, et al., “Successful Coronary Intervention of Circumflex Artery
`Originating From an Anomalous Left Main Coronary Artery Using a
`Novel Support Catheter: A Case Report and Review of Literature,” J.
`Invasive Cardiol. 2011;23(12):536-539
`2175 Pershad, et al., “GuideLiner Catheter Facilitated PCI – A Novel Device
`with Multiple Applications,” J. Invasive Cardiol. 2011;23(11):E254-
`E259
`2176 Cola, et al., “The GuidelinerTM Catheter for Stent Delivery in Difficult
`Cases: Tips and Tricks,” J. of Interventional Cardiol., Vol. 24, No. 5,
`2011, pp 450-461
`2177 Moynagh, et al., “Angiographic Success and Successful Stent Delivery
`for Complex Lesions Using the GuideLiner™ Five-in-six System- A
`Case Report,” Am Heart Hosp J. 2011;9(1):44–7
`[Reserved]
`2178
`2179 Mamas, et al., “Distal Stent Delivery with Guideliner Catheter: First in
`Man Experience,” Catheterization and Cardiovascular Interventions,
`76:102–111 (2010)
`2180 Rao, et al., “The GuideLiner™ “child” catheter,” EuroIntervention,
`2010;6:277-279
`
`

`

`2181 GuideLiner Clinical Case information titled “Contemporary Chronic
`Total Occlusion Percutaneous Coronary Intervention: GuideLiner
`Catheter and R350 Guidewire Facilitated Reverse-Cart”
`2182 GuideLiner Clinical Case information titled “Use of GuideLiner Catheter
`to Reduce Contrast in Patients with Renal Insufficiency”
`2183 GuideLiner Clinical Case information titled “GuideLiner Catheter is
`Useful Both for Support and to Minimize Contrast Load by Super-
`Selective Injections in a High-Risk Chronic Renal Failure Patient”
`[Reserved]
`2184
`2185 GuideLiner Clinical Case information titled “Complex Primary PCI ST
`Elevation Myocardial Infarction Facilitated by the GuideLiner Catheter”
`2186 GuideLiner Clinical Case information titled “GuideLiner Catheter
`Facilitates Treatment of Calcific Ostial Circumflex Artery Despite
`Severe Retroflexion”
`[Reserved]
`2187
`2188 GuideLiner Clinical Case information titled “GuideLiner Catheter Used
`for Proximal to Distal Stent Technique”
`2189 GuideLiner Clinical Case information titled “Successful Use of
`GuideLiner Catheter to Treat Sequential Distal Carotid Artery Stenoses”
`[Reserved]
`2190
`2191 GuideLiner Clinical Case information titled “Successful Multi-Stent
`Delivery in a Heavily Calcified Right Coronary Artery Using the
`GuideLiner Catherter”
`2192 GuideLiner Clinical Case information titled “Successful Distal Stent
`Delivery Past Multiple Previous Stents Made Possible by the Guideliner
`Catheter”
`2193 GuideLiner Clinical Case information titled “Successful Transradial Use
`of the GuideLiner Catheter to Selectively Treat Severe Disease in the
`LAD”
`2194 Fabris, et al., “Guide extension, unmissable tool in the armamentarium
`of modern interventional cardiology. A comprehensive review,”
`International Journal of Cardiology 222 (2016) 141–147
`[Reserved]
`2195
`Information Disclosure Statement for U.S. Patent App. 14/210,572
`2196
`2197 PowerPoint Presentation titled “Proximal SA Tracker Week 28” –
`PROTECTIVE ORDER MATERIAL
`2198 PowerPoint Presentation titled “GLYDER RX Guide Extension
`Catheter” – PROTECTIVE ORDER MATERIAL
`[Reserved]
`
`2199
`
`

`

`2200 Guidezilla Guide Extension Catheter 501(k) Summary
`2201 Glyder Team Meeting, June 9th, 2019 – PROTECTIVE ORDER
`MATERIAL
`2202 Email regarding competitive product spend freeze – PROTECTIVE
`ORDER MATERIAL
`2203 Med Device Online: Medtronic to acquire PercuSurge for $225 million
`2204 Medtronic Press Release: Medtronic Launches Telescope ™ Guide
`Extension Catheter to Support Complex Coronary Cases
`2205 Declaration of Heather S. Rosecrans
`2206 Declaration of James Phelan in Opposition to Motion for Preliminary
`Injunction
`[Reserved]
`2207
`2208 Medtronics GuardWire Information Website
`2209 GuideLiner Catheter Instructions For Use
`2210 Guidezilla Guide Extension Catheter (5-in-6) Instruction For Use
`2211 Guidant Product Catalog
`2212 U.S. Patent No. 5,290,247 (Crittenden)
`2213 Lee, et al., “Saphenous Vein Graft Intervention,” JACC: Cardiovascular
`Interventions, Vol. 4, No. 8, 2011:831-43
`2214 QX Médical Boosting Catheter website
`2215 Declaration of Dr. Craig Thompson
`2216 Declaration of Alexander S. Rinn
`2217
`[Reserved]
`2218
`[Reserved]
`2219
`[Reserved]
`2220
`[Reserved]
`2221
`[Reserved]
`2222
`[Reserved]
`2223
`[Reserved]
`2224
`[Reserved]
`2225
`[Reserved]
`2226
`[Reserved]
`2227
`[Reserved]
`2228
`[Reserved]
`2229
`[Reserved]
`2230
`[Reserved]
`2231
`[Reserved]
`2232
`[Reserved]
`2233
`[Reserved]
`
`

`

`[Reserved]
`2234
`[Reserved]
`2235
`[Reserved]
`2236
`2237 Deposition Transcript of Dr. Paul Zalesky dated January 13, 2021
`2238 Deposition Transcript of Dr. Stephen Brecker dated January 14, 2021
`2239
`[Reserved]
`2240 Deposition Transcript of Stephen Brecker, M.D. dated January 19, 2021
`2241 Deposition Transcript of Michael Jones dated January 20, 2021
`2242 Deposition Transcript of Paul Zalesky, Ph.D. – PROTECTIVE ORDER
`MATERIAL
`[Reserved]
`2243
`2244 Deposition Transcript of Richard Hillstead, Ph.D., dated April 13, 2021
`2245 Deposition Transcript of Stephen Brecker, M.D. dated April 20, 2021
`2246 Guidezilla Guide Extension Catheter (5-in-6) Instructions for Use
`2247 Telescope Guide Extension Catheter Instructions for Use
`2248 Deposition Transcript of Steven Erb, dated October 29, 2020
`2249 Deposition Transcript of Dr. John J. Graham, MB ChB, MRCP (UK)
`dated November 18, 2020
`[Reserved]
`2250
`[Reserved]
`2251
`2252 Declaration of Dean Peterson
`2253 Gregg Sutton Lab Notebook
`2254 Memo Regarding Market Feasibility for the GuideLiner catheters
` – PROTECTIVE ORDER MATERIAL
`2255 Howard Root Notes
`2256 Project Spend Report
`2257
`Invoice from MicroGroup
`2258 Declaration of Shelleaha L. Jonas in Support of Patent Owner’s
`Unopposed Motion for Pro Hac Vice Admission
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`
`
`Dated: June 25, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/ J. Derek Vandenburgh /
`
`
`J. Derek Vandenburgh (Lead Counsel)
`Registration No. 32,179
`Carlson, Caspers, Vandenburgh
` & Lindquist, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Telephone: (612) 436-9600
`Facsimile: (612) 436-9650
`Email: DVandenburgh@carlsoncaspers.com
`
`Lead Counsel for Patent Owner
`
`
`

`

`CERTIFICATION OF SERVICE
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.6(e) and the agreement of the parties, the
`
`undersigned certifies that on June 25, 2021, a true and correct copy of the
`
`foregoing Patent Owner Updated Exhibit List was served via electronic mail upon
`
`the following:
`
`Cyrus A. Morton (Reg. No. 44,954)
`Sharon Roberg-Perez (Reg. No. 69,600)
`Christopher A. Pinahs (Reg. No. 76,375)
`Ryan Dornberger
`Robins Kaplan LLP
`800 LaSalle Avenue, Suite 2800
`Minneapolis, MN 55401
`Phone: 349-8500
`Fax: 612-339-4181
`Email: Cmorton@robinskaplan.com
`Email: Sroberg-perez@robinskaplan.com
`Email: Cpinahs@robinskaplan.com
`Email: Rdornberger@robinskaplan.com
`
`
`
`
`
`
`
`
`/J. Derek Vandenburgh/
`
`
`
`
`
`J. Derek Vandenburgh (Lead Counsel for Patent Owner)
`
`
`
`
`
`
`
`
`
`